Russia's Sputnik V Vaccine 91.6% Effective In Late-Stage Trial: Lancet - TMS ShortLINK
News Update
Loading...
Without Label Russia's Sputnik V Vaccine 91.6% Effective In Late-Stage Trial: Lancet

Tuesday, February 2, 2021

Russia's Sputnik V Vaccine 91.6% Effective In Late-Stage Trial: Lancet

      Comment   
----YOU ADS---
----YOU ADS---
Russia's Sputnik V vaccine is 91.6 percent effective against symptomatic Covid-19, according to results published in The Lancet on Tuesday that independent experts said allayed transparency concerns... ----YOU ADS---
----YOU ADS---

Share with your friends

Give us your opinion

How To Use
  • Put the link on the
  • Generate Link box with http:// or https://
  • Use  CTRL + V  on keyboard to put the link.
  • Click Generate button to get encrypted link.
  • Click Copy URL button.
    • Done